论文部分内容阅读
目的:分析189例肿瘤标志物检测(AFP:甲胎球蛋白;CEA:癌胚抗原;FER:铁蛋白;PSA:前列腺特异性抗原;HCG:促绒毛膜性腺激素)在临床疾病中应用价值。方法:应用化学发光法—检测血清中肿瘤标志物含量。结果:男性60岁以上AFP增高,CEA各年龄组差异无显著性,FER在70岁～80岁之间组增高存在差异,PSA在70岁以上明显增高;女性AFP、CEA 80岁以上增高最明显,FER在60岁～70岁之闻组增高存在差异,HCG 60岁以下轻度增高,但差异无显著性。结论:不论男女联合检测阳性对肿瘤预测价值要高于单项检测,尤其年龄段的不同对诊断更有参考意义。
OBJECTIVE: To analyze the clinical value of detecting 189 tumor markers (AFP: meylobulin; CEA: carcinoembryonic antigen; FER: ferritin; PSA: prostate specific antigen; HCG: promoting chorionic gonadotropin) in clinical diseases. Methods: The chemiluminescence method was used to detect the content of tumor markers in serum. Results: The AFP in men over 60 years old was higher than that in CEA groups. There was no significant difference in CEA among all age groups. There was difference in FER between the age of 70 and 80 years, PSA was significantly higher than 70 years old. , FER in the 60-year-old group of 70-year-old smell increased there is a difference, HCG slightly increased 60 years of age, but no significant difference. Conclusion: The combined detection of male and female positive predictive value of the tumor higher than the single test, especially in different age groups more useful for the diagnosis of reference.